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Chronic alcohol consumption is a major risk factor for the
development of chronic pancreatitis. However, chronic
pancreatitis occurs only in a minority of heavy drinkers.
This variability may be due to yet unidentified genetic
factors. Several enzymes involved in the degradation of
reactive oxidants and xenobiotics, such as glutathione-S-
transferase P1 (GSTP1) and manganese–superoxide dis-
mutase (MnSOD) reveal functional polymorphisms that
affect the antioxidative capacity and may therefore
modulate the development of chronic pancreatitis and
long-term complications like endocrine and exocrine
pancreatic insufficiency. Two functional polymorphisms
of the MnSOD and the GSTP1 gene were assessed by
polymerase chain reaction and restriction fragment length
polymorphism in 165 patients with chronic alcoholic
pancreatitis, 140 alcoholics without evidence of pancreatic
disease and 160 healthy control subjects. The distribution
of GSTP1 and MnSOD genotypes were in Hardy–
Weinberg equilibrium in the total cohort. Genotype and
allele frequencies for both genes were not statistically
different between the three groups. Although genotype
MnSOD Ala/Val was seemingly associated with the
presence of exocrine pancreatic insufficiency, this sub-
group was too small and the association statistically
underpowered. None of the tested genotypes affected the
development of endocrine pancreatic insufficiency. Poly-
morphisms of MnSOD and GSTP1 are not associated
with chronic alcoholic pancreatitis. The present data
emphasize the need for stringently designed candidate
gene association studies with well-characterized cases and
controls and sufficient statistical power to exclude chance
observations.
Introduction
Chronic pancreatitis is a progressive inflammatory disorder that
eventually leads to exocrine and/or endocrine insufficiency.
Long-term alcohol consumption is the predominant cause for
the development of chronic pancreatitis which, however,
develops only in about 5–10% of heavy drinkers (1).
Compelling evidence for an important genetic background in
the development of chronic pancreatitis derives from the
detection of mutations in the cationic trypsinogen (2), the
pancreatic serine protease inhibitor Kazal type 1 (3) and
the cystic fibrosis gene (4). However, most human data point
against a decisive role of the above mentioned mutations in the
pathophysiology of chronic alcoholic pancreatitis (CAP), so,
other genetic modifiers are likely responsible. In this regard,
candidate gene association studies have investigated the
relationship between the development of CAP and single-
nucleotide polymorphisms (SNPs) of genes that play a role in
the pathophysiology of pancreatic injury (5–8).
Oxidative stress plays an important role in the evolution of
CAP since reactive oxygen species (ROS) generated during
oxidative alcohol degradation lead to cellular and subcellular
damage (9–11). Herewith, variants of genes that code for
antioxidant enzymes, such as glutathione-S-transferases (GSTs)
and manganese–superoxide dismutase (MnSOD), could mod-
ulate the susceptibility to develop CAP.
GSTs are a family of four isoenzymes (GSTA, GSTM,
GSTT and GSTP) that inactivate ROS and xenobiotics through
conjugation with glutathione (GSH) (12). The isoenzyme
GSTP1 is expressed in biliary epithelial and pancreatic stellate
cells, and its gene reveals a polymorphism which leads to an
amino acid substitution (Ile/Val) at codon 105 resulting in
a 3-fold decreased capability of GSTP1 to detoxify 1-chloro-
2,4-dinitrobenzene (13) and to deactivate 4-hydroxynonenal,
a highly reactive product of lipid peroxidation (14). We have
recently identified genotype GSTP1 Val/Val as a genetic risk
factor for the development of liver cirrhosis in patients with
hereditary hemochromatosis, a disease in which oxidative
stress is the pivotal trigger of tissue injury (15).
Mitochondria-derived ROS are detoxified to hydrogen
peroxide and water by the successive action of MnSOD and
GSH peroxidase, respectively (16). MnSOD is synthesized
with a cleavable target sequence that enables its transport into
mitochondria (17). A dimorphism (C/T) at codon 16 leads to
either alanine (Ala) or valine (Val) at amino acid position 9
of the target sequence resulting in its enhanced translocation
into mitochondria and a 40% higher concentration of active
MnSOD in case of the Ala sequence (18,19). Previous human
studies focused on the role of MnSOD variants in the evolution
of alcoholic liver disease but yielded controversial results with
a positive association in the initial report (20) and negative
findings in the later, and larger, study (21).
In spite of the crucial role of oxidative stress in the evolution
of CAP, only few small studies investigated the role of
functional polymorphisms of genes encoding GST and
MnSOD isoenzymes (22–25) with inconclusive results.
Therefore, in the present study, we investigated whether
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genetic polymorphisms of GSTP1 and MnSOD are associated
with the occurrence of chronic pancreatitis and its complica-
tions in a large cohort of heavy drinkers.
Patients and methods
Patients
The total study cohort comprised 305 alcoholic patients
enrolled between 2000 and 2003 and 160 healthy individuals
(118 men, 42 women) from hospital and research laboratory
staff who served as a reference population with regard to the
distribution of MnSOD and GSTP1 genotypes. All included
patients were Caucasians of German descent. The present and
past daily alcohol intake of all recruited alcoholic subjects was
recorded through standardized interrogation during a face-
to-face interview. Into the two groups of alcoholics, female and
male patients with active or recent heavy alcohol consumption
as defined by at least 80 g/day for .10 years were included.
Patients were assigned to either group CAP or group of
alcoholics without pancreatitis (ALC). Diagnosis of CAP was
based on a history of long-lasting heavy alcohol consumption
and the presence of chronic pancreatitis as evidenced by
histologic criteria and/or a combination of morphologic,
functional and clinical findings. A diagnosis of chronic
pancreatitis was considered confirmed if a score of 4 or more
was achieved using the previously described Mayo Clinic
Score (26): 4, typical histological changes; 4, pancreatic
calcification; 3, characteristic findings on endoscopic retro-
grade cholangiopancreatography, and 2, exocrine pancreatic
insufficiency (steatorrhea by abnormal quantitative fecal fat
excretion .7 g/day or an abnormal secretin–pancreozymin test
result). A score of 2 was assigned for attacks of pancreatitis
and/or chronic upper abdominal pain, and a score of 1 was
assigned for diabetes mellitus (glucose intolerance requiring
continuous control by diet or with addition of oral agents or
insulin).
The diagnosis of chronic diarrhea due to pancreatic
maldigestion was based on the diagnosis of chronic pancrea-
titis, increased frequency (.3/day) and liquidity of stools, and
exocrine pancreatic insufficiency proven by steatorrhea,
abnormal secretin–pancreozymin test result or fecal elastase 1
concentration ,200 lg/g stool in three different stool samples
(27). Other causes of diarrhea had to be excluded and stool
samples were lyophilized before determination of elastase 1 to
prevent false low results (28). The presence of exocrine
pancreatic insufficiency applied to 75 of 165 patients with
CAP. Endocrine pancreatic insufficiency was defined by the
presence of diabetes mellitus together with decreased starving
serum insulin and C-peptide concentrations, and the absence of
criteria of the metabolic syndrome which was present in 36 of
165 patients with CAP.
ALC were active heavy drinkers recruited from patients
admitted to the hospital for alcohol detoxification. Absence of
alcoholic pancreatitis or liver cirrhosis was confirmed by the
absence of clinical, biochemical, radiological and/or endo-
scopic evidence. Subjects included in this group belonged to
a subgroup of 174 alcoholic patients previously genotpyed in a
study testing alcohol dehydrogenase 1C polymorphisms as
a possible genetic risk factor for alcohol-related cancers (29).
Of these patients, 34 were excluded for the present study
because of clinical signs of infection and/or and accident
injuries.
The study protocol was reviewed and approved by the local
Ethics Committees of the four participating centers (Erlangen,
Heidelberg, Regensburg and Lu¨beck), and all patients and
healthy volunteers gave written informed consent prior to
inclusion.
Mutation analysis
For genotyping procedures, genomic DNA was isolated from
peripheral blood using the QIAamp blood DNA extraction kit
(Qiagen GmbH, Hilden, Germany). Polymerase chain reactions
(PCRs) were performed with 100–200 ng of genomic DNA in
a 25-ll reaction volume containing 0.2 mmol of each primer,
200 mmol of nucleotides (Peqlab Biotechnologies, Erlangen,
Germany) and 2.5 U AmpliTaq Gold polymerase (Qiagen
GmbH). All primers were synthesized by MWG Biotech,
Ebersberg, Germany.
The GSTP1 codon 105 polymorphism was analyzed as
reported (15) using as forward primer 5#-ACC CCA GGG
CTC TAT GGG AA-3# and as reverse primer 5#-TGA GGG
CAC AAG AAG CCC CT-3#. After a ‘hot start’ at 95C, the
conditions were set at 35 cycles at 95C for 1 min, followed by
60C for 1 min and 72C for 1 min, and a final extension at
72C for 10 min. For restriction fragment length polymorphism
analysis, the 176-bp amplification product was digested with
BsmA1 (New England Biolabs, Frankfurt, Germany) at 55C
for 12 h giving rise to either an undigested 176-bp fragment,
representing the Ile105-encoding allele, or two fragments of 91
and 85 bp, respectively, representing the Val105-encoding allele.
The PCR procedure to determine MnSOD genotypes was
carried out as previously described (15) by using the following
primers (MWG Biotech): forward primer 5#-CAG CCC AGC
CTG CTG AGA CGG-3# and reverse primer 5#-CTT GGC
CAA CGC CTC CTG GTA CTT-3#. The reaction volumes and
the cycling conditions were the same as for the GSTP1
genotyping procedure. The PCR generated an amplicon of 267
bp that was subjected to digestion with endonuclease BsaW1
(New England Biolabs) for 12 h at 60C. This restriction
enzyme only cuts the MnSOD amplification product into two
fragments of 183 and 84 bp, respectively, when a thymine is
present at position 1183 of the MnSOD gene (Val construct).
The digestion products were analyzed on 2.5% agarose gel as
detailed for GSTP1. In order to assure the reliability of the
genotyping methods, 25% of DNA samples was genotyped
twice by two examiners (F.S. and J.S.).
Statistical analysis
Student’s t-test was conducted to test for differences in means
between groups. Skewed data as assessed by the Kolmogorov–
Smirnov test were summarized by median and range.
Comparison of these groups or groups with unequal variances,
as assessed by Levine’s test, was done by applying the Mann–
Whitney U-test. Categorical data were summarized by
frequencies and analyzed by a chi-square test. Binary logistic
regression analysis with forward and backward stepwise
inclusion of variables was calculated to assess the impact of
laboratory and clinical data and of GSTP1 and MnSOD
genotypes on the presence of alcoholic pancreatitis and
endocrine and exocrine pancreatic insufficiency. P-values of
,0.05 (two-tailed) were considered significant. A commercially
available software program SPSS10.0 (SPSS Inc., Chicago, IL,
USA) was used for all calculations. Testing for deviation
from Hardy–Weinberg equilibrium was done by the use of
the following homepage: http://ihg.gsf.de/cgi-bin/hw/hwa1.pl.
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Sample size–power calculation was done by the use of the
following homepage: http://www.meduniwien.ac.at/medstat/
research/samplesize/ssize.html.
Results
A total number of 465 individuals were recruited for this study
and genotyped for genetic variants of MnSOD and GSTP1.
Table I summarizes the demographic characteristics of the two
patient groups. Patients with CAP were predominantly male
and significantly older than ALC. The proportion of smokers
was generally high in both groups but even larger in those with
CAP. Due to the large recall bias, only present alcohol
consumption was quantified and expressed in grams per day,
whereas past alcohol consumption was only estimated in terms
of length of consumption and recorded in years of consump-
tion. Only patients with an alcohol history of at least 10 years
were considered eligible for inclusion. Alcoholics without
chronic pancreatitis drank significantly more alcohol than
patients with CAP. Healthy control subjects drank little or no
alcohol at all (,20 g), but 23% of all included subjects were
smokers.
Table II shows the genotype and allele frequencies of both
studied genes in patients with CAP, chronic alcoholics and
healthy controls. There was no difference in the frequency of
genotypes and alleles between these three groups. In particular,
genotype distribution in healthy controls did not differ from
chronic alcoholics and patients with CAP. The distribution of
GSTP1 and MnSOD variants were in Hardy–Weinberg
equilibrium in the total cohort.
In order to account for the significant differences in the
demographic characteristics of the two groups of alcoholics
with regard to gender and age, as well as for alcohol and
tobacco consumption, a logistic regression analysis was
conducted. Results are presented in Table III. Herein, age,
gender, alcohol and tobacco consumption were identified as
independent risk factors for the development of alcoholic
chronic pancreatitis. Since none of the genotypes were found
associated with chronic pancreatitis as assessed by chi-square
test, they were not included in the logistic model.
In a subgroup analysis of patients with CAP who developed
exocrine pancreatic insufficiency, a well-known complication
of chronic pancreatitis, patients with exocrine pancreatic
insufficiency carried more frequently MnSOD genotype Ala/
Val than those without (68.0% versus 46.7%, P 5 0.022)
(Table IV). Age, gender, smoking habits and alcohol
consumption did not differ significantly between patients with
and without exocrine pancreatic insufficiency, respectively.
However, the distribution of MnSOD genotypes in this
subgroup of patients was not in Hardy–Weinberg equilibrium
(P 5 0.002).
In patients with chronic pancreatitis, neither GSTP1 nor
MnSOD genotypes had an impact on the presence of endocrine
pancreatic insufficiency (Table V).
Discussion
Our study is among the largest so far to investigate the impact
of SNPs of antioxidant enzymes on the development of chronic
pancreatitis in heavy drinkers, and the first to study their
potential association with well-established complications of
chronic pancreatitis. Neither of the two tested functional
genetic polymorphic variants was associated with the chronic
pancreatitis in alcoholics. The genotyping results presented in
our study were in Hardy–Weinberg equilibrium for both genes
which render genotyping errors rather unlikely. Moreover,
genotype and allele frequencies in our cohort complied with
published data from other studies (20,21,30) and with the
reference HapMap database (31).
In previous studies by other researchers, genotype MnSOD
Ala/Ala was shown to increase the mitochondrial enzyme
activity of MnSOD by 40% compared with the other two
genotypes (19). So, patients with genotype MnSOD Ala/Ala
should have a higher endogenous antioxidant capacity pro-
viding a better resistance towards oxidative stress typically
encountered in CAP, whereas carriers with MnSOD Val/Val
should be more prone to develop alcohol-related pancreatic
injury. This would seem even more important since both
manganese and copper/zinc SOD enzymes are induced during
the spontaneous development of chronic pancreatitis in male
WBN/Kob rats (32). Moreover, transgenic mice over-expressing
copper/zinc SOD are more resistant to caerulein-induced acute
pancreatitis (33). Also, transgenic mice with increased beta-
cell expression of MnSOD and catalase showed a markedly
Table I. Characterization of patients and control subjects
Total Alcoholics without
chronic pancreatitis
(n 5 140)
Alcoholics with
chronic pancreatitis
(n 5 165)
P values
Males, N (%) 101 (72.1) 136 (82.4) 0.032
Age (years)
Mean  SD 46.2  10.4 41.9  9.5 49.9  9.7 ,0.001
Median (range) 45 (22–82) 41 (22–72) 48 (30–82) ,0.001
Alcohol, g/day
Mean  SD 173.6  151.7 251.1  145.3 109.9  125.7 ,0.001
Median (range) 120 (0–800) 200 (60–800) 80 (0–800) ,0.001
Smokers, N (%) 246 (80.7) 105 (75.0) 141 (85.5) 0.021
Pancreatic calcifications, N (%) — — 76 (46.1) —
Pancreatic pseudocysts, N (%) — — 60 (36.4) —
Elastase activity (lg/g) — — —
With exocrine pancreatic insufficiency 96.6  51.3
Without exocrine pancreatic insufficiency 402.1  80.5
Others, N (%) — — 32 (19.4) —
Others: pancreatic duct stenosis (n 5 5), pancreas necrosis (n 5 3), pancreas edema (n 5 1), gastric/duodenal ulcer (n 5 18), liver cirrhosis (n 5 4) and splenic
vein thrombosis (n 5 1).
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higher expression of these antioxidant enzymes, increased
beta-cell ROS scavenging and improved beta-cell survival
after treatment with different sources of ROS (34). Although
the functional implications are attractive, their relevance is
not reflected by the data from our case–control association
study.
The lack of association between GSTP1 and MnSOD
genotypes, and CAP confirms data from another recent report
in which patients with CAP were included (25). In this
relatively small analysis, only 75 patients with CAP were
included in addition to 33 patients with idiopathic chronic
pancreatitis and 13 individuals with hereditary pancreatitis. No
association was found for variants of both genes, but
a significantly higher frequency of genotype GSTT1*A was
detected in patients with idiopathic chronic pancreatitis.
However, this association seems largely underpowered with
a subgroup size of 33 patients, and is likely attributable to
a type-I error which refers to false-positive associations
frequently seen in studies with a low sample size. On the
other hand, our data contrast with another study from Brazil
that reported an association of genotype GSTP1 Val/Val with
chronic pancreatitis in alcoholics, but only 14 patients with
pancreatitis were analyzed. Again, such a small sample size is
too small to draw firm conclusions.
Although the pathophysiology of acute and chronic
pancreatitis are distinct, interestingly, our data are in line with
a previous study by Rahman et al. (22) who investigated the
role of polymorphisms of a battery of antioxidant enzymes
including GSTM1, T1, and P1, manganese superoxide
dismutase (Ala-9Val) and catalase (c-260T) in the development
of acute pancreatitis, a disease somehow distinct from chronic
pancreatitis. The authors genotyped 320 patients with acute
pancreatitis due to alcohol consumption (n 5 66), biliary
diseases (n 5 194) or other causes (n 5 60), as well as 263
control subjects. They found an association between the
functional GSTT-1*A genotype and severe versus mild acute
pancreatitis. This genotype was also associated with higher C-
reactive protein levels and acute physiology scores. However,
this association only held true for acute pancreatitis due to
biliary causes, but not for that related to alcohol consumption.
As regards GSTP1 genotypes and the development of CAP,
Verlaan et al. (23) made similar observations, however, in
a much smaller number of patients. In their study, the GSTM1-
null genotype was found to be a protective factor towards the
evolution of chronic pancreatitis due to alcohol, but not
towards other etiologies.
Apart from demonstrating the lack of association between
the two tested genes and CAP, our study illustrates the need to
apply stringent quality criteria when performing candidate gene
association studies. The controversy between strong associa-
tions of candidate genes and certain disease end points in initial
reports and the inability to reproduce these data in subsequent
studies is mostly due to the fact that results of ‘index’ studies
were obtained in small case–control studies with an incomplete
characterization of cases and controls. Often, no statistical
correction for potential confounding factors, such as alcohol
consumption, cigarette smoking and age, was performed and
many other pivotal aspects in designing this kind of study were
not adopted. In this regard, several prerequisites for the design
Table III. Results of binary logistic regression analysis
Factor Parameter
estimate
SE parameter
estimate
Odds ratio (95% CI) P value
Age 0.090 0.017 * ,0.001
Alcohol 0.008 0.001 * ,0.001
Male sex 0.967 0.349 2.630 (1.327–5.209) 0.006
Smoking 1.250 0.426 3.489 (1.515–8.035) 0.003
*For the variables age and alcohol no odds ratio was calculated, since both
variables were not classified into groups and were entered as continuous
variables in the regression model.
Table IV. Association of genotypes and alleles with exocrine pancreatic
insufficiency
Exocrine pancreas insufficiency P-value
Absent (n 5 90) Present (n 5 75)
GSTP1, N (%)
Ile/Ile 30 (33.3) 35 (46.7) 0.156
Ile/Val 47 (52.2) 34 (45.3)
Val/Val 13 (14.4) 6 (8.0)
Ile 0.59 0.69 0.062
Val 0.41 0.31
MnSOD, N (%)
Ala/Ala 27 (30.0) 13 (17.3) 0.022
Ala/Val 42 (46.7) 51 (68.0)
Val/Val 21 (23.3) 11 (14.7)
Ala 0.53 0.51 0.717
Val 0.47 0.49
Table II. Results of genotyping analysis
Healthy
controls
(n 5 160)
Alcoholics
without chronic
pancreatitis
(n 5 140)
Alcoholics
with chronic
pancreatitis
(n 5 165)
P value*
GSTP1, N (%)
Ile/Ile 75 (46.9) 54 (38.6) 65 (39.4) 0.647*
Ile/Val 64 (40.0) 74 (52.9) 81 (49.1)
Val/Val 21 (13.1) 12 (8.6) 19 (11.5)
Ile 0.67 0.65 0.64 *0.785
Val 0.33 0.35 0.36
MnSOD, N (%)
Ala/Ala 43 (26.9) 42 (30.0) 40 (24.2) *0.059
Ala/Val 81 (50.6) 60 (42.9) 93 (56.4)
Val/Val 36 (22.5) 38 (27.1) 32 (19.4)
Ala 0.52 0.51 0.52 *0.806
Val 0.48 0.49 0.48
*Comparing alcoholics with pancreatitis.
Table V. Association of genotypes and alleles with endocrine pancreatic
insufficiency
Endocrine pancreas insufficiency P value
Absent (n 5 129) Present (n 5 36)
GSTP1, N (%)
Ile/Ile 53 (41.1) 12 (33.3) 0.676
Ile/Val 62 (48.1) 19 (52.8)
Val/Val 14 (10.9) 5 (13.9)
Ile 0.65 0.60
Val 0.35 0.40 0.399
MnSOD, N (%)
Ala/Ala 30 (23.3) 10 (27.8) 0.359
Ala/Val 71 (55.0) 22 (61.1)
Val/Val 28 (21.7) 4 (11.1)
Ala 0.51 0.58 0.256
Val 0.49 0.42
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of genotype/phenotype association studies are currently
considered crucial (35–37): (i) there should be a logical
rationale for the chosen candidate genes and a coherent
hypothesis based on the functional significance of the studied
genetic variants; (ii) in case–control studies, several function-
ally related genes should be tested since this approach has
a higher chance to detect genetic risk factors than the screening
of single genetic variants; (iii) inclusion of well-characterized
cases and controls ensuring a comparable exposure to the
pathogenic insult (i.e. alcohol); (iv) a study sample with
a homogeneous ethnic genetic background; (v) control for or
exclusion of other confounding factors and (vi) application of
accepted standards for statistical analysis and sample size,
especially with regard to the size of the group of ‘cases’ (i.e.
CAP). As regards the latter, a sample size of 150 in the ‘case’
group has recently been defined as a critical threshold for the
replication validity of genetic association studies (38). All these
demands were considered in the present study. Therefore, in
summary, our data indicate that GSTP1 and MnSOD genotypes
can be firmly considered irrelevant in the development of
CAP as well as their complications exocrine and endocrine
pancreatic insufficiency.
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